SHINE Achieves Visible Proof of Fusion
SHINE Technologies has demonstrated clearly visible Cherenkov radiation produced by fusion for what is believed to be the first time in history, the company announced today. “Fusion has long captured…
Category Archives: Biotech
NorthStar, Bayer Establish Agreement
NorthStar Medical Radioisotopes announced today that it will provide Bayer with its environmentally preferred, non-carrier added (n.c.a.) therapeutic medical radioisotope, actinium‐225 (Ac‐225). “We are very pleased to enter this Ac-225…
InvivoSciences Gearing up for FDA Application
Story provided by Alex Moe, WisBusiness.com. InvivoSciences, a pre-clinical stage biotech firm based in Madison, is gearing up for a potential FDA application for a heart failure drug and companion…
Exact Sciences Adds Two New Partners
Exact Sciences is partnering with two renowned healthcare organizations at the forefront of cancer research, the Broad Institute of MIT and Harvard along with Baylor Scott & White, the company…
SHINE Opens New Facility
SHINE Technologies announced today it is opening the largest facility in North America dedicated to producing a medical isotope used in targeted cancer therapies. According to a release, the facility,…
Exact Sciences Sees Improvement in Next-Gen Cologuard
Exact Sciences plans to submit next-generation Cologuard tests for FDA approval, the company announced recently. According to a release, the results from its BLUE-C study saw 94 percent sensitivity for…
Phoenix Increases Capacity to Meet Neutron Imaging Demand
Phoenix has increased its capacity for neutron imaging this year by 20%, the company announced today. According to a release, the upcoming closing of GE Hitachi’s Vallecitos Nuclear Center in…
SHINE Launches Radiation Effects Testing
SHINE Technologies is now offering state-of-the-art radiation effects testing, the company announced today. According to a release, the service, called FLARE (Fusion Linear Accelerator for Radiation Effects), will use high-energy…
WARF, Ginkgo Bioworks to Partner
The Wisconsin Alumni Research Foundation (WARF) has partnered with Boston-based Ginkgo Bioworks to discover next-generation GD2 CAR T-cell therapies, the organization announced today. According to a release, CAR T-cell therapies…
Type One Energy Raises $29M
Type One Energy has closed on a $29 million financing round, the organization announced today. According to a release, the funding was co-led by Breakthrough Energy Ventures (BEV), TDK Ventures…
